These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 4056986)

  • 41. Treatment of children with a single dose a day of sustained release theophylline.
    Pedersen S
    Br J Clin Pharmacol; 1982 Aug; 14(2):290-1. PubMed ID: 7104183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
    Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans.
    Harrison LI; French IW; Mildon CA
    Clin Ther; 1982; 4(6):489-96. PubMed ID: 7093982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
    Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW
    S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB; Schwartz RH; Brooks JG
    Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of food on the absorption rate and bioavailability of a sustained release theophylline preparation.
    Pedersen S; Moeller-Petersen J
    Allergy; 1982 Oct; 37(7):531-4. PubMed ID: 7181050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative bioavailability of two sustained-release theophylline formulations versus an immediate-release preparation.
    Williams RL; Upton RA; Bostrom A
    J Asthma; 1983; 20(1):27-30. PubMed ID: 6343339
    [No Abstract]   [Full Text] [Related]  

  • 49. Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects.
    Osman MA; Patel RB; Irwin DS; Welling PG
    Biopharm Drug Dispos; 1983; 4(1):63-72. PubMed ID: 6839003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetics of a new slow-release theophylline preparation in asthmatic children].
    Nieto A; Mazón A; Caballero L; Gil MC
    An Esp Pediatr; 1985 Apr; 22(5):383-92. PubMed ID: 4014892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.
    D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger H; Steinijans VW
    Am Rev Respir Dis; 1990 Jul; 142(1):84-90. PubMed ID: 2195936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum theophylline levels in asthmatic children after oral administration of two slow-release theophylline preparations.
    McKenzie S; Baillie E
    Arch Dis Child; 1978 Dec; 53(12):943-6. PubMed ID: 747398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selection of a slow-release theophylline product.
    Hendeles L; Weinberger M
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):743-51. PubMed ID: 3534055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets.
    Kelly HW; Murphy S
    Am J Hosp Pharm; 1979 Dec; 36(12):1698-701. PubMed ID: 525646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.
    Williams PE; Alwazir YA; Routledge PA; Campbell IA
    Br J Clin Pharmacol; 1986 Oct; 22(4):383-7. PubMed ID: 3768254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal time for obtaining peak and trough theophylline levels in 12-hour and 24-hour products in children.
    Tinkelman DG; Lutz CN; Miller E; Cole WQ
    Ann Allergy; 1987 Mar; 58(3):190-2. PubMed ID: 3826771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a once-a-day theophylline preparation in asthmatic children.
    Tang RB; Wu KG; Chao T; Chang YR; Hwang B
    J Asthma; 1992; 29(4):273-80. PubMed ID: 1634452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of Nuelin-SR 250 mg in asthmatic children: a new sustained-release theophylline.
    Mitchell EA; Liang AY
    N Z Med J; 1980 Aug; 92(665):91-3. PubMed ID: 6933343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.